In Latin America there are 596,000 new cases registered annually and more than 142,000 deaths due to this condition.
Surviving breast cancer and patients with this disease at the stage of metastasis must they receive additional treatments with therapeutic approaches which help them improve the quality of life.
"However, this practice, unfortunately, is not widespread or widespread among health teams"Sergio Zuniga said in a statement.
The specialist explained that Nutrition and exercise are key factors of lifestyle and that they should be prescribed by a multidisciplinary team in all breast cancer patients or by the development of metastases.
Zuniga, who is an academician at the University of the Mexican Valley, UVM, said that there are clinical trials that emphasize the importance of nutrition counseling, patient's functionality and quality of life.
These studies, he explained, are repeating the sudden change in the landscape of surviving women with metastatic breast cancer, especially in the past five years.
"So, the need to have clear guidelines for enriching or increasing the quality of life of these patients"he said.
The specialist said that it is necessary to consider many women who suffer or survive breast cancer They struggle with unwanted healing effects, including weight loss, functionality in everyday life or other more demanding.
"So if these changes can improve the burden of symptoms and affect the desired quality of life in a positive way, we can say that it is largely fulfilled by the comprehensive treatment of survivors of breast cancer." commented on Zuniga.
According to the World Health Organization, WHO, Every year, 1.38 million new cases of breast cancer have been discovered worldwide and consequently Because of this disease there are 458,000 deaths.
By this time Pan American Health Organization, PAHOin Latin America there are 596,000 new cases registered annually and more than 142,000 deaths due to this condition, which is the second cause of death from malignant tumors among women in the region.